GE HealthCare Technologies Inc. Common Stock (GEHC) Financials
Key financial figures for GE HealthCare Technologies Inc. Common Stock (Q2 2026).
GE HealthCare grew revenue 5.7% to $5.3 billion in Q2 2026, with Adjusted EPS of $1.13 (+6.6% YoY), as Pharmaceutical Diagnostics strength offset a continued double-digit decline in Patient Care Solutions. Revenue reached $5.295 billion, up 5.7% YoY (3.5% organic), with Pharmaceutical Diagnostics and the new Advanced Imaging Solutions segment driving growth Adjusted EPS of $1.13 grew 6.6% YoY; GAAP diluted EPS of $1.24 grew 16.5% YoY; Adjusted EBIT margin was 14.2% Pharmaceutical Diagnostics revenue jumped 15.6% to $843 million (14.6% organic), the strongest-performing segment Advanced Imaging Solutions (the newly combined Imaging + Advanced Visualization Solutions segment) grew 7.9% to $3,771 million (5.0% organic) Patient Care Solutions revenue fell 13.3% to $675 million (-13.5% organic); mana. On the outlook: Reaffirmed full-year 2026 guidance, unchanged from Q1 2026: organic revenue growth of 3.0% to 4.0%, Adjusted EBIT margin of 15.4% to 15.7%, Adjusted EPS of $4.80 to $5.00, and free cash flow of approximately $1.6 billion. Figures are for Q2 2026, as GE HealthCare Technologies Inc. reported them.
- Revenue
- $5.3B
- Net Income
- $573M
- EPS
- $1.24
- Total Assets
- $37.2B
- Operating Cash Flow
- $168M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $5.3B | $573M | $1.24 | 13.96% | -$617M |
| Q1 FY2026 | $5.1B | $389M | $0.85 | 10.04% | $112M |
| Q4 FY2025 | $4.7B | $184M | $0.38 | 14.21% | $917M |
| Q3 FY2025 | $5.1B | $446M | $0.98 | 12.7% | $483M |
| Q2 FY2025 | $5.0B | $486M | $1.06 | 13.06% | $8M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $20.6B | $2.1B | $4.55 | 13.39% | $1.5B |
| FY2024 | $19.7B | $2.0B | $4.34 | 13.34% | $1.6B |
| FY2023 | $19.6B | $1.6B | $3.02 | 12.45% | $1.7B |
Frequently asked questions
What was GE HealthCare Technologies Inc.'s revenue last quarter?
GE HealthCare Technologies Inc. reported revenue of $5.30 billion for Q2 FY2026, up 5.8% from the same period a year earlier.
Is GE HealthCare Technologies Inc. profitable?
Yes. GE HealthCare Technologies Inc. reported net income of $573.0 million for Q2 FY2026, a net margin of 10.82% on revenue.
How has GE HealthCare Technologies Inc.'s margin trended?
Operating margin was 13.96% in Q2 FY2026, compared with 13.06% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did GE HealthCare Technologies Inc. generate?
GE HealthCare Technologies Inc. generated free cash flow of -$617.0 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for GE HealthCare Technologies Inc. Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.